Pediatric Hepatoblastoma: A Single-Institution Case Series

Authors

Keywords:

Hepatoblastoma in Children, Neoadjuvant Therapy, Prune Belly Syndrome, Vesicoureteral Reflux

Abstract

Introduction: Hepatoblastomas comprise up to two-thirds of malignant liver masses in childhood and rank as the third most common malignant neoplasm in children under the age of three. Treatment and prognosis are highly dependent on tumor staging and characteristics. Our study’s aim is to analyze the clinical findings and outcomes of hepatoblastoma at our institution.

Methods: After Institutional Review Board (IRB) approval was granted from Loma Linda University #5240020, we conducted a retrospective review on all patients under the age of 18 with a diagnosis of hepatoblastoma between February 2000 to January 2022. Variables assessed included demographics, work up, surgical intervention, recurrence, and mortality.

Results: Fifteen patients were diagnosed with hepatoblastoma in that timeframe. Mean age was 18.7 months. Associated comorbidities included three patients with prematurity, one patient with Beckwith-Wiedemann Syndrome, and two unique presentations each of Prune Belly Syndrome and grade IV/V vesicoureteral reflux. There were four mortalities, two due to relapse in disease, one due to pulmonary and CNS metastasis at diagnosis, and another due to sepsis and multi-organ failure. Eleven patients continued monitoring without tumor recurrence. All patients were treated based on the Children’s Oncology Group (COG) guidelines.

Conclusion: Risk stratification is an important component of hepatoblastoma management. Our cohort demonstrated novel comorbidities of Prune Belly Syndrome and vesicoureteral reflux. Eleven patients received neoadjuvant chemotherapy that allowed for subsequent surgical resection. Our mortalities were associated with tumor metastasis and recurrence consistent with elevated alpha-fetoprotein (AFP) values. Future research should involve multi-institutional studies focusing on comorbidities and genetic analysis.

Metrics

Metrics Loading ...

Author Biography

Andrei Radulescu, MD, PhD. Division of Pediatric Surgery, Department of Surgery, Loma Linda University Children’s Hospital, Loma Linda, CA, USA.

 

 Loma Linda University School of Medicine, Loma Linda, CA, USA.

References

Küpesiz, F. T., Akınel, A. N., Akbaş, H., Sivrice, Ç., Kintrup, G. T., Karagüzel, G., et al. Multidisciplinary Management of Pediatric Hepatoblastoma: A 20-Year Single-Center Experience. The Turk J Gastroenterol. 2022;33(12):1069.

Zhang Y, Zhang W, Tang S, Chen L, Yi Y, Zhang P, et al. A single-center retrospective study of pediatric hepatoblastoma. Oncoly. Lett. 2016 Nov 1;12(5):3919-25.

Pateva, I. B., Egler, R. A., & Stearns, D. S. Hepatoblastoma in an 11-year-old: Case report and a review of the literature. Medicine. 2017 Jan 1:, 96(2): e5858.

Lack, E. E., Neave, C., & Vawter, G. F. Hepatoblastoma: A clinical and pathologic study of 54 cases. Am J Surg Pathol. 1982 Dec 1;6(8):693-705.

Spector, L. G., & Birch, J. The epidemiology of hepatoblastoma. Pediatr Blood Cancer. 2012 Nov;59(5):776-9.

El Asmar, A., & El Rassi, Z. Hepatoblastoma in childhood, long term survival achieved: 2 case reports and literature review. Int. J. Surg. Case Rep. 2016 Jan 1;21:55-8.

Hager, J., & Sergi, C. M. Hepatoblastoma. Exon Publications. 2021 Apr 6:145-64.

Hiyama, E. Pediatric hepatoblastoma: diagnosis and treatment. Transl. Pediatr. 2014 Oct;3(4):293.

Meyers, R., Hiyama, E., Czauderna, P., & Tiao, G. M. Liver tumors in pediatric patients. Surg. Oncol. Clin. N. Am.. 2021 Apr 1;30(2):253-274.

Kulkarni, S., Brauer, D. G., Turmelle, Y., Stoll, J., Nadler, M., Chapman, W. C., et al. Surgical therapy for pediatric hepatoblastoma in the USA over the last decade: analysis of the national cancer database. J Gastrointest Cancer. 2021 Jun; 52:547-556.

Bharti S, Bharti JN, Sinha A, Yadav T. Common and rare histological variants of hepatoblastoma in children: a pathological diagnosis and review of the literature. Gastrointest. Tumors. 2021 Apr 8;8(2):41-6.

Abdul-Rahman OA, Edghill EL, Kwan A, Enns GM, Hattersley AT. Hypoplastic glomerulocystic kidney disease and hepatoblastoma: a potential association not caused by mutations in hepatocyte nuclear factor 1β. J Pediatr Hemato Oncol. 2009 Jul 1;31(7):527-9.

Sattler B, Gunawan B, Lorf T, Müller D, Ringe B, Füzesi L. Undifferentiated small-cell hepatoblastoma. Der Pathologe. 2000 Nov 1;21(6):456-9.

Sebestyen J, Garg U, Lewing KB, Warady BA, Abdel-Rahman S, Blowey DL. Cisplatin pharmacokinetics in a child receiving peritoneal dialysis. Pediatr Nephrol. 2010 Jun;25:1185-9.

Khosla A. Hepatoblastoma and congenital dysplastic kidney. J Pediatr Surg. 1990 Aug;25(8):924.

Majidinia M, Aghazadeh J, Jahanban-Esfahiani R, Yousefi B. The roles of Wnt/-catenin pathway in tissue development and regenerative medicine. J Cell Physiol. 2018 Aug; 223(8):5598-612

Becknell B, Pais P, Onimoe G, Rangarajan H, Schwaderer AL, McHugh K, Ranalli MA, Hains DS. Hepatoblastoma and prune belly syndrome: a potential association. Pediatr Nephrol. 2011 Aug;26:1269-73.

Sharma, D., Subbarao, G., & Saxena, R. Hepatoblastoma. Seminars in diagnostic pathology. 2017 Mar 1 (Vol. 34, No. 2, pp. 192-200). WB Saunders.

Perilongo, G., Malogolowkin, M., & Feusner, J. Hepatoblastoma clinical research: lessons learned and future challenges. Pediatr Blood Cancer. 2012 Nov; 59(5):818-21.

Agha RA, Sohrabi C, Mathew G, Franchi T, Kerwan A, O’Neill N for the PROCESS Group. The PROCESS 2020 Guideline: Updating Consensus Preferred Reporting Of Case Series in Surgery (PROCESS) Guidelines, Int. J Surg. 2020;60

Zhou S, Malvar J, Chi YY, Stein J, Wang L, Genyk Y, Sposto R, Mascarenhas L. Independent assessment of the children’s hepatic tumors international collaboration risk stratification for hepatoblastoma and the association of tumor histological characteristics with prognosis. JAMA Netw Open. 2022 Feb 1;5(2):e2148013-.

Srinivasan S, Prasad M, Parambil BC, Shrimal A, Gollamudi VR, Subramani V, Ramadwar M, Khanna N, Baheti AD, Gala K, Patil V. Treatment outcomes and prognostic factors in children with hepatoblastoma using a risk‐stratified approach. Pediatr Blood Cancer. 2023 Jul;70(7):e30302.

Downloads

Published

2024-11-19

How to Cite

Sawaya, J., McRae, J., Mladenov, G. D., & Radulescu, A. (2024). Pediatric Hepatoblastoma: A Single-Institution Case Series. International Journal of Medical Students. Retrieved from https://ijms.info/IJMS/article/view/2735

Issue

Forthcoming

Section

Experience

Categories

License

Copyright (c) 2024 Jessica Sawaya, Joyce McRae, Georgi D. Mladenov, Andrei Radulescu

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

  1. The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
  2. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
  3. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
    1. Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
    2. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
    3. Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
    4. Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
    5. The Author represents and warrants that:
      1. the Work is the Author’s original work;
      2. the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
      3. the Work is not pending review or under consideration by another publisher;
      4. the Work has not previously been published;
      5. the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
      6. the Work contains no libel, invasion of privacy, or other unlawful matter.
    6. The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.

Enforcement of copyright

The IJMS takes the protection of copyright very seriously.

If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.

If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org

 

Infringing material

If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org